Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Retinoic Acid Receptor (RAR) - Drugs in Development, 2021
US$ 3,000.00
Retinoic Acid Receptor (RAR) - Drugs in Development, 2021 SUMMARY Retinoic Acid Receptor (RAR) - Drugs in Development, 2021 provides in depth analysis on Retinoic Acid Receptor (RAR) targeted pipeline...
April 2021
35 pages
Retinoid X Receptor (RXR) - Drugs in Development, 2021
US$ 3,000.00
Retinoid X Receptor (RXR) - Drugs in Development, 2021 SUMMARY Retinoid X Receptor (RXR) - Drugs in Development, 2021 provides in depth analysis on Retinoid X Receptor (RXR) targeted pipeline therapeu...
April 2021
30 pages
Retinopathy (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Retinopathy (Ophthalmology) - Drugs in Development, 2021 SUMMARY Retinopathy (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Retinopathy pipeline landscape. The report provide...
April 2021
40 pages
Sarcoidosis (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Sarcoidosis (Immunology) - Drugs in Development, 2021 SUMMARY Sarcoidosis (Immunology) - Drugs in Development, 2021 provides an overview of the Sarcoidosis pipeline landscape. The report provides comp...
April 2021
45 pages
Scar (Dermatology) - Drugs in Development, 2021
US$ 2,000.00
Scar (Dermatology) - Drugs in Development, 2021 SUMMARY Scar (Dermatology) - Drugs in Development, 2021 provides an overview of the Scar pipeline landscape. The report provides comprehensive informati...
April 2021
55 pages
Sclerostin (SOST) - Drugs in Development, 2021
US$ 3,000.00
Sclerostin (SOST) - Drugs in Development, 2021 SUMMARY Sclerostin (SOST) - Drugs in Development, 2021 provides in depth analysis on Sclerostin (SOST) targeted pipeline therapeutics. The report provide...
April 2021
35 pages
Sepsis (Infectious Disease) - Drugs in Development, 2021
US$ 2,500.00
Sepsis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Sepsis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Sepsis pipeline landscape. The report provides com...
April 2021
230 pages
Septic Shock (Other Diseases) - Drugs in Development, 2021
US$ 2,000.00
Septic Shock (Other Diseases) - Drugs in Development, 2021 SUMMARY Septic Shock (Other Diseases) - Drugs in Development, 2021 provides an overview of the Septic Shock pipeline landscape. The report pr...
April 2021
50 pages
